Defence Online

Type of document: Contract Notice
Country: United Kingdom
Publication Ref: (2024/S 000-014932/EN)
Nature of contract: Service contract
Procedure: Open procedure
Type of bid required: Global bid

Contract notice
Services

Section I: Contracting authority
I.1) Name and addresses
Official name: Ministry of Defence
Town: Salisbury
Country: United Kingdom
Email: phaggerty1@dstl.gov.uk
Internet address(es):
Main address:

I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge,at:
Additional information can be obtained from:
the above mentioned address
Tenders or requests to participate must be submitted:
electronically via:
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local sub-divisions
I.5) Main activity
Defence

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Antibody Production
II.1.2) Main CPV code: 73111000
II.1.3) Type of contract: Services
II.1.4) Short Description: The Authority requires the production of batches of purified monoclonal antibody (mAb) derived from hybridoma cell lines. The Authority will supply the contractor with cell lines as Government Furnished Assets (GFA) with the requirement that they are cultured and monoclonal antibodies purified from growth media. Requests will be for approximately 20 batches per year of 20 mg and approximately 10 batches of 100 mg of purified IgG over a 6 year period.

II.1.6) Information about lots:
The contract is divided into lots: no
II.2) Description
II.2.3) Place of performance
Nuts code:
II.2.4) Description of the procurement:
The Authority requires the production of batches of purified monoclonal antibody (mAb) derived from hybridoma cell lines. The Authority will supply the contractor with cell lines as Government Furnished Assets (GFA) with the requirement that they are cultured and monoclonal antibodies purified from growth media. Requests will be for approximately 20 batches per year of 20 mg and approximately 10 batches of 100 mg of purified IgG over a 6 year period.
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
End: 2030-03-31
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options: no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure:
Open procedure
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 2024-05-31 Local time: 12:00
IV.2.4) Languages in which tenders or requests to participate may be submitted:EN
IV.2.7) Conditions for opening tenders
Date: 2024-06-14 Local time: 16:00

Section VI: Complementary information
VI.1) Information about recurrence:
This is a recurrent procurement: no
VI.2) Information about electronic workflows
VI.4) Procedures for review
VI.4.1) Review body
Official name: Dstl
Town: Porton Down, Salisbury
Country: United Kingdom
VI.5) Date of dispatch of this notice:2024-05-10